SelectScience is organising a new webinar, “Biosimilar Characterization: Leveraging Protein Analytical Technology Within GMP Guidelines to Design a Pathway to a Successful Product” on 17th of October.
Learn about the advantages of using QTof MS data for the characterization of a biosimilar candidate, to meet the standards of regulatory bodies such as the U.S.FDA and EMA, through case study examples.
Dr. Michelle Maxwell, Drug Discovery & Development Editor at SelectScience, will be hosting the webinar which will be followed by a live Q&A session. A certificate of attendance can be provided upon request.
You can check more details about this webinar from here.